391 related articles for article (PubMed ID: 18686778)
1. Radionuclide carriers for targeting of cancer.
Sofou S
Int J Nanomedicine; 2008; 3(2):181-99. PubMed ID: 18686778
[TBL] [Abstract][Full Text] [Related]
2. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
4. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
Ting G; Chang CH; Wang HE; Lee TW
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for Cystic Fibrosis.
Ong V; Mei V; Cao L; Lee K; Chung EJ
SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
[TBL] [Abstract][Full Text] [Related]
6. New partnership to explore cancer nanotherapeutics.
Stanwix H
Bioanalysis; 2013 Feb; 5(3):273. PubMed ID: 23516708
[No Abstract] [Full Text] [Related]
7. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
8. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
9. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
Hamoudeh M; Kamleh MA; Diab R; Fessi H
Adv Drug Deliv Rev; 2008 Sep; 60(12):1329-46. PubMed ID: 18562040
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment.
Zhang L; Zhai BZ; Wu YJ; Wang Y
Drug Deliv; 2023 Dec; 30(1):1-18. PubMed ID: 36597205
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
Muthu MS; Singh S
Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
13. Transcellular transfer of nanomedicine.
Jang HL; Sengupta S
Nat Nanotechnol; 2019 Aug; 14(8):731-732. PubMed ID: 31263193
[No Abstract] [Full Text] [Related]
14. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
15. Lipoproteins as carriers for organ-imaging radiopharmaceuticals.
Counsell RE; Schwendner SW; DeForge LE; DeGalan MR; Newton RS
Targeted Diagn Ther; 1991; 5():251-314. PubMed ID: 1797169
[No Abstract] [Full Text] [Related]
16. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules.
Holgado MA; Martin-Banderas L; Alvarez-Fuentes J; Fernandez-Arevalo M; Arias JL
Curr Med Chem; 2012; 19(19):3188-95. PubMed ID: 22612702
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
18. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
Xu J; Liao K; Jiang H; Zhou W
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents.
Bhagat M; Halligan S; Sofou S
Curr Pharm Biotechnol; 2012 Jun; 13(7):1306-16. PubMed ID: 22201591
[TBL] [Abstract][Full Text] [Related]
20. Inorganic nanoparticles in cancer therapy.
Bhattacharyya S; Kudgus RA; Bhattacharya R; Mukherjee P
Pharm Res; 2011 Feb; 28(2):237-59. PubMed ID: 21104301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
